from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Registered capital THB 50 million, divided into 500,000

financial statements in accordance with Thai Financial Reporting of Thailand (TFRS) which is adjusted to conform to International Financial Reporting Standards (IFRS). All financial information to be

generated total revenues of 1,093 million Baht; or decreasing by 49% as compared to the total revenues in Q3 2017 of 2,132 million Baht. This was mainly due to the increase in revenue from sales of the

% Amount % Q2-17 VS Q2-16 Q2-17 VS Q1-17 Sales Revenue 12,296 100.0 11,273 100.0 12,127 100.0 9.1 1.4 Gross profit 3,123 25.4 3,070 27.2 3,218 26.5 1.7 (3.0) Operating profit 1,441 11.7 1,222 10.8 1,377 11.4

in Q2 2019 dropped by 2.40% compared to last year. Export Volume dropped by 2.52% due to the global economic slowdown as overall economy may be affected by the international trade war. Domestic demands

Company and its subsidiaries as follows: Performance Ending December 31, 2017 Revenue from Sales and Services In 2017, the Company and its subsidiaries generated revenues of THB 7,786 million from the sales

clarification of the performance of the Company and its subsidiaries as follows: Performance Ending December 31, 2017 Revenue from Sales and Services In 2017, the Company and its subsidiaries generated revenues

(Restate) 2018 YoY Total Revenue 46,306 53,461 48,781 5% -9% 172,138 192,025 12% Accounting EBITDA 3,616 4,161 (317) -109% -108% 13,421 10,201 -24% Refinery and Trading Business Group 1/ 2,256 2,140 (1,419

RHIS RH International (Singapore) Corporation Pte Ltd, a wholly-owned indirect subsidiary RIAU PT Medco Ratch Power RIAU, an indirect joint venture in proportion of 49 percent RL RATCH-Lao Services

growth in all major segments together with gross margin expansion. - Q1’20 Revenue from sales grew by 5.0% YoY, amounting to THB 6.7 billion, driven by the growth in all major segments particulary